United Bank Invests $2.25 Million in CVS Health Corporation $CVS

Key Points

• United Bank acquired a new $2.25 million position in CVS Health during the second quarter, purchasing 21,751 shares. Institutional investors collectively own 80.66% of the company.
• Analysts maintain a positive outlook, with 22 Buy ratings and two Holds, producing a consensus “Moderate Buy” rating and an average price target of $107.17.
• CVS reported quarterly EPS of $2.58, surpassing estimates of $1.87, while revenue rose 7.3% year over year to $106.1 billion. The company also pays a quarterly dividend of $0.665 per share, yielding about 2.8% annually.

United Bank bought a new position in CVS Health Corporation (NYSE:CVS - Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 21,751 shares of the pharmacy operator's stock, valued at approximately $2,250,000.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Caitong International Asset Management Co. Ltd grew its position in shares of CVS Health by 407.2% in the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 350 shares of the pharmacy operator's stock worth $26,000 after buying an additional 281 shares during the last quarter. Swiss RE Ltd. bought a new position in shares of CVS Health during the fourth quarter valued at approximately $26,000. Sankala Group LLC purchased a new stake in CVS Health in the fourth quarter worth $28,000. Global Trust Asset Management LLC boosted its holdings in CVS Health by 344.8% in the first quarter. Global Trust Asset Management LLC now owns 387 shares of the pharmacy operator's stock valued at $28,000 after acquiring an additional 300 shares in the last quarter. Finally, Mcguire Capital Advisors Inc. bought a new stake in CVS Health in the fourth quarter valued at $28,000. Institutional investors own 80.66% of the company's stock.

Wall Street Analysts Forecast Growth

Several research analysts have commented on the stock. Weiss Ratings upgraded shares of CVS Health from a "hold (c+)" rating to a "buy (b-)" rating in a report on Wednesday, August 5th. UBS Group boosted their price target on shares of CVS Health from $122.00 to $126.00 and gave the company a "buy" rating in a research report on Thursday, August 6th. Royal Bank Of Canada increased their price target on shares of CVS Health from $107.00 to $113.00 and gave the stock an "outperform" rating in a research note on Thursday, July 9th. Piper Sandler reissued an "overweight" rating and issued a $113.00 target price on shares of CVS Health in a report on Monday, June 1st. Finally, Sanford C. Bernstein raised their target price on CVS Health from $94.00 to $106.00 and gave the stock an "outperform" rating in a research report on Tuesday, May 12th. Twenty-two investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat, CVS Health has a consensus rating of "Moderate Buy" and an average target price of $107.17.

CVS Health Stock Down 1.4%

NYSE CVS opened at $93.58 on Thursday. The stock's 50-day moving average price is $102.32 and its 200-day moving average price is $88.69. The company has a quick ratio of 0.66, a current ratio of 0.87 and a debt-to-equity ratio of 0.74. CVS Health Corporation has a 52 week low of $69.51 and a 52 week high of $110.68. The company has a market capitalization of $119.68 billion, a P/E ratio of 24.76, a price-to-earnings-growth ratio of 0.91 and a beta of 0.61.

CVS Health (NYSE:CVS - Get Free Report) last announced its quarterly earnings data on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.87 by $0.71. The company had revenue of $106.10 billion during the quarter, compared to the consensus estimate of $100.03 billion. CVS Health had a return on equity of 13.12% and a net margin of 1.18%.The firm's revenue was up 7.3% on a year-over-year basis. During the same period in the previous year, the company posted $1.81 EPS. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. On average, equities research analysts predict that CVS Health Corporation will post 8.02 earnings per share for the current year.

CVS Health Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, August 3rd. Stockholders of record on Thursday, July 23rd were given a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a dividend yield of 2.8%. The ex-dividend date was Thursday, July 23rd. CVS Health's dividend payout ratio (DPR) is presently 70.37%.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source